The venture capital arms of Pittsburgh-based UPMC and UChicago Medicine have invested in a healthcare AI startup as part of a $55 million series C funding round.
UPMC Enterprises and UCM Ventures backed Ultromics, which says it offers the first FDA-cleared, Medicare-reimbursed AI technology to aid in detecting cardiac amyloidosis and heart failure with preserved ejection fraction. The company developed the tool in collaboration with Rochester, Minn.-based Mayo Clinic.
Ultromics’ other health system partners include Cleveland-based University Hospitals and Chicago-based Northwestern Medicine. The startup says its platform helps hospitals cut unnecessary tests, enhance workflows and start treatments earlier.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
